Sierra Oncology SRRA

$ 54.89 -0.05%

Quarterly report 2022-Q1
added 12-16-2023

Sierra Oncology Balance Sheet 2011-2024 | SRRA

Annual Balance Sheet Sierra Oncology

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-104 M	-	-	-101 M	-	-109 M	-150 M	-29.2 M	-2.02 M	-	-
Long Term Debt	485 K	-	-	4.89 M	-	-	-	-	412 K	-	-
Long Term Debt Current	368 K	207 K	187 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	175 K	374 K	4.89 M	-	-	-	1.91 M	863 K	-	-
Total Current Liabilities	12.9 M	9.35 M	64.6 M	10.1 M	7.47 M	7.72 M	7.4 M	-	-	-	-
Total Liabilities	13.4 M	9.53 M	65 M	15 M	7.47 M	7.72 M	7.4 M	4 M	1.76 M	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-941 M	-847 M	-766 M	-677 M	-624 M	-582 M	-534 M	-108 M	-34.7 M	-	-
Total Assets	109 M	107 M	151 M	109 M	102 M	111 M	153 M	40.6 M	2.46 M	-	-
Cash and Cash Equivalents	105 M	104 M	148 M	106 M	100 M	109 M	150 M	29.2 M	2.43 M	-	-
Book Value	96 M	98 M	86.3 M	94.5 M	94.7 M	103 M	145 M	36.6 M	699 K	-	-
Total Shareholders Equity	96 M	98 M	86.3 M	94.5 M	94.7 M	103 M	145 M	-108 M	-34.7 M	-	-

All numbers in USD currency

Quarterly Balance Sheet Sierra Oncology

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	4.86 M	485 K	543 K	650 K	122 K	175 K	175 K	175 K	175 K	374 K	374 K	374 K	374 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	18.4 M	13.4 M	9.17 M	10.1 M	9.01 M	9.53 M	7.68 M	9.24 M	7.3 M	65 M	65 M	65 M	65 M	15 M	15 M	15 M	15 M	7.47 M	7.47 M	7.47 M	7.47 M	7.72 M	7.72 M	7.72 M	7.72 M	7.4 M	7.4 M	7.4 M	7.4 M	4 M	4 M	4 M	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-969 M	-941 M	-916 M	-887 M	-867 M	-847 M	-829 M	-814 M	-798 M	-766 M	-766 M	-766 M	-766 M	-677 M	-677 M	-677 M	-677 M	-624 M	-624 M	-624 M	-624 M	-582 M	-582 M	-582 M	-582 M	-534 M	-534 M	-534 M	-534 M	-108 M	-108 M	-108 M	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	280 M	109 M	104 M	94.4 M	111 M	107 M	113 M	126 M	137 M	151 M	151 M	151 M	151 M	109 M	109 M	109 M	109 M	102 M	102 M	102 M	102 M	111 M	111 M	111 M	111 M	153 M	153 M	153 M	153 M	40.6 M	40.6 M	40.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	274 M	105 M	97.1 M	90.7 M	108 M	104 M	104 M	104 M	104 M	148 M	148 M	148 M	148 M	106 M	106 M	106 M	106 M	100 M	100 M	100 M	100 M	109 M	109 M	109 M	109 M	150 M	150 M	150 M	150 M	29.2 M	29.2 M	29.2 M	-	2.43 M	-	-	-	1.31 M	-	-	-	-	-	-	-
Book Value	-	-	-	262 M	96 M	95.1 M	84.3 M	102 M	98 M	105 M	117 M	129 M	86.3 M	86.3 M	86.3 M	86.3 M	94.5 M	94.5 M	94.5 M	94.5 M	94.7 M	94.7 M	94.7 M	94.7 M	103 M	103 M	103 M	103 M	145 M	145 M	145 M	145 M	36.6 M	36.6 M	36.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	262 M	96 M	95.1 M	84.3 M	102 M	98 M	105 M	117 M	129 M	86.3 M	58.8 M	70.5 M	83.6 M	94.5 M	94.5 M	94.5 M	94.5 M	94.7 M	94.7 M	94.7 M	94.7 M	103 M	103 M	103 M	103 M	145 M	145 M	145 M	145 M	-108 M	-108 M	-108 M	-	-34.7 M	-	-	-	-22.2 M	-	-	-	-	-	-	-

All numbers in USD currency